Lamicare Health Group develops patented, clinically proven dermatology products for global distribution. Our proprietary CEM-K™ active ingredient delivers up to 93% reduction in skin inflammation in independent EU clinical trials. Partnering with distributors, investors and licensing partners across 40+ countries.